Sally M. Elfishawi
Foum Elkhalig Sq
Cairo, C, Egypt
Cairo, C, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
BCR-ABL1 Transcript ≤10% IS an Early Molecular Response Predictor of Treatment-Free Remission Eligibility in Chronic Myeloid Leukemia.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 28, 2026
Clinical significance of the transcription factor (SOX11) expression in the bone marrow of acute myeloid leukemia patients.
Journal: World journal of clinical oncology
Published: March 20, 2025
Variability in expression of homeobox genes (HOXA9) and (HOXA7) in acute myeloid leukemia patients.
Journal: Current research in translational medicine
Published: August 19, 2024
Hsa-miR-21-5p reflects synovitis and tenosynovitis components of musculoskeletal ultrasonography Seven-joint scores in rheumatoid arthritis disease and predicts the disease flare.
Journal: Pathology, research and practice
Published: October 12, 2023
Overexpression of cancerous inhibitor ofPP2A (CIP2A) in acute myeloid leukemia.
Journal: Expert review of hematology
Published: May 03, 2022
Behçet disease, new insights in disease associations and manifestations: a next-generation sequencing study.
Journal: Clinical and experimental immunology
Published: November 21, 2020
Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
Journal: Annals of hematology
Published: July 21, 2020
HLA Class I in Egyptian patients with Behçet's disease: new association with susceptibility, protection, presentation and severity of manifestations.
Journal: Immunological investigations
Published: September 28, 2018
Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop.
Journal: Human immunology
Published: September 07, 2018
Last Updated: 09/26/2026